Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-067496
Filing Date
2025-05-09
Accepted
2025-05-09 07:10:19
Documents
70
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bold-20250331.htm   iXBRL 10-Q 1582095
2 EX-10.1 bold-ex10_1.htm EX-10.1 34855
3 EX-10.3(A) bold-ex10_3a.htm EX-10.3(A) 454526
4 EX-10.3(B) bold-ex10_3b.htm EX-10.3(B) 50694
5 EX-31.1 bold-ex31_1.htm EX-31.1 16653
6 EX-31.2 bold-ex31_2.htm EX-31.2 16931
7 EX-32.1 bold-ex32_1.htm EX-32.1 15854
8 GRAPHIC img147942662_0.jpg GRAPHIC 93790
9 GRAPHIC img147942662_1.jpg GRAPHIC 93790
10 GRAPHIC img148866183_0.jpg GRAPHIC 35328
  Complete submission text file 0000950170-25-067496.txt   7793980

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bold-20250331.xsd EX-101.SCH 890987
73 EXTRACTED XBRL INSTANCE DOCUMENT bold-20250331_htm.xml XML 1252431
Mailing Address 10955 ALEXANDRIA WAY SUITE 100 SAN DIEGO CA 92121
Business Address 10955 ALEXANDRIA WAY SUITE 100 SAN DIEGO CA 92121 (858) 766-9912
Boundless Bio, Inc. (Filer) CIK: 0001782303 (see all company filings)

EIN.: 830751369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41989 | Film No.: 25928362
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)